148 related articles for article (PubMed ID: 7563611)
21. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
Tverdek FP; Crank CW; Segreti J
Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
[TBL] [Abstract][Full Text] [Related]
22. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
23. A child with vancomycin-induced thrombocytopenia.
Bay A; Oner AF; Dogan M; Caksen H
J Emerg Med; 2006 Jan; 30(1):99-100. PubMed ID: 16434347
[No Abstract] [Full Text] [Related]
24. [Staphylococcal pneumonia].
Yamamoto Y; Tomono K; Kohno S
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):346-9. PubMed ID: 10088411
[No Abstract] [Full Text] [Related]
25. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus.
Ferrara AM
Int J Antimicrob Agents; 2007 Jul; 30(1):19-24. PubMed ID: 17475449
[TBL] [Abstract][Full Text] [Related]
26. [Studies on MRSA pneumonia as a complication of hematopoietic malignancies].
Niitsu N; Nakata M; Shirai T
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):25-30. PubMed ID: 8114369
[TBL] [Abstract][Full Text] [Related]
27. The risk of persistent carriage of methicillin-resistant Staphylococcus aureus in hematopoietic stem cell transplantation.
Kato N; Tanaka J; Mori A; Tutumi Y; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Ota S; Hashino S; Asaka M; Imamura M
Ann Hematol; 2003 May; 82(5):310-2. PubMed ID: 12709827
[TBL] [Abstract][Full Text] [Related]
28. New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment.
Yoshida M; Yasuda N; Nishikata M; Okamoto K; Uchida T; Matsuyama K
J Infect Chemother; 2005 Aug; 11(4):182-8. PubMed ID: 16133709
[TBL] [Abstract][Full Text] [Related]
29. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
[TBL] [Abstract][Full Text] [Related]
30. [MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases].
Erbes R; Wagner A; Schaberg T; Lode H; Mauch H; Witte W
Pneumologie; 1996 Oct; 50(10):706-11. PubMed ID: 9019751
[TBL] [Abstract][Full Text] [Related]
31. [Clinical studies on vancomycin in the treatment of MRSA infection].
Shimizu K; Orizu M; Kanno H; Kitamura S; Konishi T; Soma K; Nishitani H; Noguchi Y; Hasegawa S; Hasegawa H; Wada K
Jpn J Antibiot; 1996 Aug; 49(8):782-99. PubMed ID: 9053533
[TBL] [Abstract][Full Text] [Related]
32. Topical vancomycin for chronic suppurative otitis media with methicillin-resistant Staphylococcus aureus otorrhoea.
Jang CH; Song CH; Wang PC
J Laryngol Otol; 2004 Aug; 118(8):645-7. PubMed ID: 15453944
[TBL] [Abstract][Full Text] [Related]
33. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
Salerno D; Vahid B; Marik PE
Ann Thorac Surg; 2007 May; 83(5):1888-91. PubMed ID: 17462428
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Estes L; Orenstein R
Clin Ther; 2007 Feb; 29(2):381-3; author reply 383-4. PubMed ID: 17472831
[No Abstract] [Full Text] [Related]
35. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
[TBL] [Abstract][Full Text] [Related]
36. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.
Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH
Crit Care; 2006; 10(3):R97. PubMed ID: 16808853
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin-induced thrombocytopenia: a challenge and rechallenge.
Howard CE; Adams LA; Admire JL; Chu MA; Alred GL
Ann Pharmacother; 1997 Mar; 31(3):315-8. PubMed ID: 9066938
[TBL] [Abstract][Full Text] [Related]
38. Hematologic effects of linezolid in young children.
Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
[TBL] [Abstract][Full Text] [Related]
39. Successful salvage therapy with tigecycline after linezolid failure in a liver transplant recipient with MRSA pneumonia.
Saner FH; Heuer M; Rath PM; Gensicke J; Radtke A; Drühe N; Rüngeler EM; Nadalin S; Malagó M; Broelsch CE
Liver Transpl; 2006 Nov; 12(11):1689-92. PubMed ID: 17058251
[TBL] [Abstract][Full Text] [Related]
40. Clinical factors affecting the efficacy of vancomycin in methicillin-resistant Staphylococcus aureus pneumonia.
Shimazaki N; Hayashi H; Umeda K; Aoyama T; Iida H; Matsumoto Y
Int J Clin Pharmacol Ther; 2010 Aug; 48(8):534-41. PubMed ID: 20650045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
